Osteoporosis Management

J Womens Health (Larchmt). 2020 Mar;29(3):287-290. doi: 10.1089/jwh.2019.8195. Epub 2019 Dec 13.

Authors

Kristi Tough DeSapri^{1

2}, Pelin Batur^{3

4}

Affiliations

¹ Ob/Gyn and Internal Medicine, Northwestern Center for Sexual Medicine and Menopause, Chicago, Illinois.
² Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
³ Ob/Gyn & Women's Health Institute, Cleveland Clinic, Cleveland, Ohio.
⁴ Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.

PMID: 31834855
DOI: 10.1089/jwh.2019.8195

No abstract available

MeSH terms

Alendronate / therapeutic use
Anorexia Nervosa
Bone Density Conservation Agents / therapeutic use
Bone and Bones
Contraceptives, Oral
Disease Management*
Humans
Osteoporosis*
Parathyroid Hormone-Related Protein / therapeutic use

Substances

Bone Density Conservation Agents
Contraceptives, Oral
Parathyroid Hormone-Related Protein
abaloparatide
Alendronate